Cancer Incidence for Crown Heights So., Prospect Lefferts & Wingate, Kings (Brooklyn) County, 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Males and Females | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 509.4 | 403.4 | 387.5-419.8 | 239.8 | 463.1 | 436.4-491.0 | 269.6 | 368.3 | 348.4-389.2 |
| Oral cavity and pharynx | 9.6 | 7.4 | 5.4-9.9 | 5.2 | 10.2 | 6.6-15.1 | 4.4 | 5.7 | 3.5-8.8 |
| Esophagus | 3.4 | 2.6 | 1.5-4.3 | 2.2 | 4.2 | 2.0-7.6 | 1.2 | 1.4 | 0.5-3.3 |
| Stomach | 14.0 | 11.7 | 9.0-14.8 | 7.8 | 16.1 | 11.3-22.3 | 6.2 | 8.9 | 6.0-12.8 |
| Colorectal | 45.2 | 36.3 | 31.6-41.4 | 18.6 | 36.2 | 29.0-44.7 | 26.6 | 36.0 | 30.0-42.9 |
| Colon excluding rectum | 33.6 | 26.9 | 22.9-31.4 | 12.6 | 24.1 | 18.3-31.0 | 21.0 | 28.3 | 23.0-34.5 |
| Rectum & rectosigmoid | 11.6 | 9.4 | 7.1-12.2 | 6.0 | 12.2 | 8.1-17.6 | 5.6 | 7.7 | 5.0-11.2 |
| Liver / intrahepatic bile duct | 8.6 | 6.2 | 4.4-8.4 | 6.2 | 11.2 | 7.5-16.1 | 2.4 | 2.9 | 1.5-5.3 |
| Pancreas | 16.4 | 12.8 | 10.1-16.0 | 6.0 | 11.2 | 7.5-16.3 | 10.4 | 13.5 | 10.1-17.9 |
| Larynx | 2.4 | 1.9 | 0.9-3.3 | 2.0 | 4.0 | 1.9-7.4 | 0.4 | 0.6 | 0.1-2.3 |
| Lung and bronchus | 34.8 | 27.5 | 23.5-32.0 | 16.4 | 33.0 | 26.0-41.2 | 18.4 | 24.3 | 19.5-29.9 |
| Melanoma of the skin | 1.6 | 1.5 | 0.6-2.9 | 0.8 | 1.8 | 0.5-4.6 | 0.8 | 1.2 | 0.3-3.2 |
| Female breast | 82.2 | 116.3 | 105.0-128.5 | ||||||
| Cervix uteri | 7.4 | 10.6 | 7.3-14.8 | ||||||
| Corpus uterus and NOS | 27.4 | 34.3 | 28.6-40.8 | ||||||
| Ovary | 7.0 | 9.0 | 6.2-12.8 | ||||||
| Prostate | 103.2 | 189.0 | 172.5-206.6 | ||||||
| Testis | 2.2 | 4.3 | 2.1-7.8 | ||||||
| Urinary bladder (incl. in situ) | 11.4 | 9.3 | 7.0-12.1 | 7.0 | 14.9 | 10.3-20.9 | 4.4 | 5.9 | 3.7-9.0 |
| Kidney and renal pelvis | 15.4 | 12.4 | 9.7-15.6 | 9.8 | 19.7 | 14.4-26.2 | 5.6 | 7.5 | 4.9-11.0 |
| Brain and other central nervous system | 6.0 | 4.6 | 3.1-6.6 | 3.2 | 5.9 | 3.3-9.8 | 2.8 | 3.7 | 2.0-6.3 |
| Thyroid | 16.4 | 13.8 | 10.9-17.3 | 2.4 | 5.0 | 2.5-8.8 | 14.0 | 20.8 | 16.1-26.6 |
| Hodgkin lymphoma | 2.4 | 2.0 | 1.0-3.5 | 1.2 | 2.3 | 0.8-5.1 | 1.2 | 1.8 | 0.6-3.9 |
| Non-Hodgkin lymphomas | 14.6 | 12.8 | 10.0-16.2 | 8.0 | 17.4 | 12.4-23.9 | 6.6 | 9.6 | 6.5-13.6 |
| Myeloma | 17.6 | 13.6 | 10.9-16.9 | 8.8 | 17.3 | 12.4-23.5 | 8.8 | 11.4 | 8.2-15.4 |
| Leukemias | 13.4 | 11.4 | 8.8-14.6 | 8.2 | 17.8 | 12.6-24.3 | 5.2 | 7.1 | 4.6-10.5 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.
